HOTLINE 24/7/365 UK: +44 (0) 1483 212150

Contact Us

This page should not be used to provide any information concerning adverse reactions or medical enquiries. This page is purely intended for questions relating to PharSafer® as a company.

To request a brochure please tick here.
Send me a brochure

We will auto enrol you to receive our newsletter. To opt out please tick here.
Opt Out


PharSafer House, White Hart Meadows, Ripley, Surrey GU23 6ND, UK

Direct: +44 (0) 1483 212155
Reception: +44 (0) 1483 212150
Fax: +44 (0) 1483 212178

Click to open a larger map

PharSafer® Tweets

The @EU_Commission and @EMA_News have released their latest communication, regarding a one year delay to the MDR 2…

Read on Twitter...

UPDATE: @MedDRAMSSO has released its guidance for the correct usage of new coronavirus specific terms, when reporti…

Read on Twitter...

The @EU_Commission and @EMA_News have released guidance for the safe management of clinical trials during the COVID…

Read on Twitter...